Feasability Study of a Provocative Test for Chronic Mesenteric Ischemia Using I-FABP

Feasability Study of a Provocative Test for Chronic Mesenteric Ischemia Using I-FABP - IFABP- CMI- PILOT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022376

Enrollment

Registered

2020-08-13

Start date

2020-08-14

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K55.1

Interventions

Group 1: In 5 patients with clinical and radiological sings of chronic mesenteric ischemia serum I-FABP (Intestinal Fatty- Acid- Binding- Protein) is measured before and after a testmeal. Group 2: In

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: typical symptoms of a chronic mesenteric ischemia (postprandial abdominal pain, weight loss) AND 70- 100% stenosis of superior mesenteric artery (angiographic or CT- diagnosis) AND additional stenosis or occlusion of celiac artery (angiographic or CT- diagnosis)

Exclusion criteria

Exclusion criteria: age under 18 years; pregnancy; Crohn`s disease; ulcerative colitis; history of resection of stomach, small bowel or pancreas; cholecystectomy within last 6 weeks; known vasculitis; NSAID consumtion (COX1- or COX2- inhibition) within last 24 hours (except Asprin 10mmol/l; galcactosemia.

Design outcomes

Primary

Measure	Time frame
elevated serum-I-FABP-levels in CMI-patients after testmeal	—

Secondary

Measure	Time frame
time-course of I-FABP-Levels, patient`s discomfort after testmeal	—

Countries

Germany

Contacts

Public ContactStefan Ludewig

Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Jena

stefan.ludewig@med.uni-jena.de+4936419322600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026